Claes Ginman

Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial

Anders Widmark, Adalsteinn Gunnlaugsson, L. Beckman et al. · The Lancet · 2019 · 840 citations

Surgical Oncology, Radiation Therapy, Medicine +8

2-weekly versus 3-weekly docetaxel to treat castration-resistant advanced prostate cancer: a randomised, phase 3 trial

Pirkko‐Liisa Kellokumpu‐Lehtinen, Ulrika Harmenberg, Timo Joensuu et al. · The Lancet Oncology · 2013 · 205 citations

Urology, Oncology, Genitourinary Cancer +5

Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer (HYPO-RT-PC): patient-reported quality-of-life outcomes of a randomised, controlled, non-inferiority, phase 3 trial

Per Fransson, Per Nilsson, Adalsteinn Gunnlaugsson et al. · The Lancet Oncology · 2021 · 151 citations

Radiation Medicine, Radiation Therapy, Medicine +8

Patient-controlled dose regimen of methadone for chronic cancer pain.

Juliette Säwe, Jacob J. Hansen, Claes Ginman et al. · BMJ · 1981 · 108 citations · Full text

Pain Therapy, Substance Abuse, Health Sciences +14

Adipose Tissue Concentrations of Persistent Organic Pollutants and the Risk of Prostate Cancer

Lennart Hardell, Swen‐Olof Andersson, Michael Carlberg et al. · Journal of Occupational and Environmental Medicine · 2006 · 91 citations